Back

Learner’s Digest International (TM)

  • Allergic Fungal Sinusitis
  • Immunotherapy
  • Rhinosinusitis
  • Thyroid Neoplasms

Thyroid Cancer/Immunotherapy/Chronic Rhinosinusitis

The goal of this program is to improve classification of thyroid cancers, management of head and neck cancer using immunotherapy, and diagnosis and management of chronic rhinosinusitis (CRS). After hearing and assimilating this program, the clinician will be better able to: 1. Identify histological and molecular features that distinguish low-risk neoplasms from aggressive thyroid cancers. 2. Assess eligibility for immunotherapy in patients with head and neck cancer. 3. Integrate immunotherapy into multidisciplinary care plans, including surgery or radiation, for head and neck cancer. 4. Devise individualized treatment plans for patients with CRS. 5. Recognize clinical and pathophysiological features of allergic fungal rhinosinusitis.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABOHNS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 2, 2028 2 years left